Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon- β1b (MIRACLE trial): study protocol for a randomized controlled trial

DiscussionThis will be the first randomized controlled trial of a potential treatment for MERS. The study is sponsored by King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. Enrollment for this study began in November 2016, and has enrolled thirteen patients as of Jan 24-2018.Trial registrationClinicalTrials.gov, ID:NCT02845843. Registered on 27 July 2016.
Source: Trials - Category: Research Source Type: clinical trials